The largest database of trusted experimental protocols

Opal multiplex fihc kit

Manufactured by PerkinElmer
Sourced in United States

The Opal Multiplex fIHC kit is a fluorescence-based immunohistochemistry solution designed for the simultaneous detection and visualization of multiple biomarkers in a single tissue section. The kit provides a comprehensive suite of reagents, including primary antibodies, fluorophore-conjugated secondary antibodies, and a multispectral imaging platform, enabling researchers to conduct in-depth analysis of complex biological systems.

Automatically generated - may contain errors

4 protocols using opal multiplex fihc kit

1

Multiplex Immunofluorescence for Tumor Microenvironment

Check if the same lab product or an alternative is used in the 5 most similar protocols
mIHC/IF was performed using an Opal Multiplex fIHC kit (PerkinElmer, Inc, Waltham, Massachusetts, USA), as previously described by our group and in other studies.25 31–52 (link) Tissue sections (4 µm thick) were labeled with primary antibodies against CD38, CD8 and CD68, followed by appropriate secondary antibodies. All antibodies used are listed in online supplementary table 2. This was followed by the application of a fluorophore-conjugated tyramide signal amplification buffer (PerkinElmer, Inc) and the nuclear counterstain DAPI. A Vectra three pathology imaging system microscope (PerkinElmer, Inc) was used to obtain images, and these were analyzed using inForm software (V.2.4.2; PerkinElmer, Inc)34 47 53 54 (link) and HALO TM (Indica Labs, Albuquerqe, New Mexico, USA).55–59 (link)
The density of CD38+CD68+ macrophages and CD8+ T cells were determined as follows: cell count per predefined, high-powered field (334 μm × 250 μm) represents the density of CD38+CD68+ macrophages and CD8+ T cells in the TME. Samples were then categorized as ‘high’ or ‘low’ according to whether the CD38+CD68+ macrophage and CD8+ T cell count was above the cut-off points (best thresholds) that produced the lowest p value, which were determined using previously described methods.25 31 32 36 37 43–52 60 61 (link)
+ Open protocol
+ Expand
2

Multiplex Immunofluorescence for PD-1 and CD8

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multiplex immunofluorescence (mIF) was performed using an Opal Multiplex fIHC kit (PerkinElmer, Inc., Waltham, MA, USA) as previously described by our group and other studies [45 , 61 (link)–71 ], on FFPE tissue sections processed according to the standard immunohistochemistry protocol described above. Slides were labeled with primary antibodies against PD-1 and CD8, followed by appropriate secondary antibodies (as presented in Additional file 1: Table S2), before application of the fluorophore-conjugated tyramide signal amplification buffer (PerkinElmer, Inc., Waltham, MA, USA). DAPI was used as a nuclear counterstain. Images were acquired using a Vectra 3 pathology imaging system microscope (PerkinElmer, Inc.) and analyzed using inForm version 2.3 software (PerkinElmer, Inc.) [63 (link), 72 (link), 73 ].
CD8 was stained using Opal 540 (Catalog No. FP1494001KT) while PD-1 was stained by using Opal 620 (Catalog NO. FP1495001KT). The counterstain DAPI was from Catalog No. FP1490. They were purchased from PerkinElmer, Inc., Waltham, MA, USA.
+ Open protocol
+ Expand
3

Multiplex Immunofluorescence for Tissue Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multiplex immunofluorescence was performed using an Opal Multiplex fIHC kit (PerkinElmer, Inc., Waltham, MA, USA), on FFPE tissue sections processed according to the standard immunohistochemistry protocol. Slides were incubated with primary antibodies against cytokeratin (CK), CD14, CD206, GM-CSF, and TNFα (as presented in Table S1), followed by appropriate secondary antibodies, before application of the fluorophore-conjugated tyramides signal amplification buffer (PerkinElmer, Inc., Waltham, MA, USA). DAPI was used as a nuclear counterstain, and images were acquired using a Vectra 3 pathology imaging system microscope (PerkinElmer, Inc.) and analysed using inForm version 2.3 software (PerkinElmer, Inc.). Mean intensities of each stain were determined in the nucleus, cytoplasm and membrane of individual cells delineated in each image. For DAPI, nucleus quantification was used but for the other stainings, cytoplasmic quantification was used rather than membrane quantification to limit contaminating signals coming from neighbouring cells. Data were next analysed by histo-cytometry using the FlowJo software (Tree Star). Merged images of CD14 and GM-CSF co-stainings were obtained using the Image J 1.51m9 software.
+ Open protocol
+ Expand
4

Multiplex Immunofluorescence for Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Multiplex immunofluorescence (mIF) was performed using an Opal Multiplex fIHC kit (PerkinElmer, Inc., Waltham, MA, USA) as previously described by our group and other studies (20 (link), 20 (link), 27 (link)–36 (link)), on FFPE tissue sections. TMA sections of 4 μm thickness were incubated with primary antibodies against CD38 and CD68, followed by appropriate secondary antibodies (Supplementary Table 2). Following this, a fluorophore-conjugated tyramide signal amplification buffer (PerkinElmer, Inc.) was applied, and DAPI was used as a nuclear counterstain. Images were acquired using a Vectra 3 pathology imaging system microscope (PerkinElmer, Inc.) and analyzed using inForm software (version 2.4.1; PerkinElmer, Inc.) (28 (link), 37 (link), 38 (link)). Maximally selected rank statistics (39 (link)) were applied using the maxstat R package to find optimal cut-off points for variables with good survival outcome prediction (Cutoff for CD38+ macrophages = 56.9%, whereas cutoff for CD68 immune infiltrates = 19.2%).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!